MAPT and Alzheimer disease: Another study has shown that the suppression of IL-1β in the triple transgenic (3 × Tg) mouse model of AD restores cognitive abilities, reduces tau pathology, and reestablishes the function of the neuronal beta–catenin pathway [52].